Invention Grant
US08367077B2 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
有权
包含衍生自细胞系中产生的流感病毒的血细胞凝集素的病毒体，组合物，制造方法，其用途
- Patent Title: Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
- Patent Title (中): 包含衍生自细胞系中产生的流感病毒的血细胞凝集素的病毒体，组合物，制造方法，其用途
-
Application No.: US12666260Application Date: 2008-06-13
-
Publication No.: US08367077B2Publication Date: 2013-02-05
- Inventor: Rinaldo Zurbriggen , Christian Moser , Andreas Kammer , Mario Amacker , Nicole Westerfeld , Silvia Rasi
- Applicant: Rinaldo Zurbriggen , Christian Moser , Andreas Kammer , Mario Amacker , Nicole Westerfeld , Silvia Rasi
- Applicant Address: CH Ittlingen
- Assignee: Pevion Biotech, AG
- Current Assignee: Pevion Biotech, AG
- Current Assignee Address: CH Ittlingen
- Agency: Riverside Law LLP
- Priority: EP07012283 20070622
- International Application: PCT/EP2008/004780 WO 20080613
- International Announcement: WO2009/000433 WO 20081231
- Main IPC: A61K47/00
- IPC: A61K47/00 ; A61K9/127
Abstract:
The present invention relates to virosomes comprising hemagglutinin (HA) with improved fusion activity. Preferably, the HA comprised in said virosomes was derived from influenza virus produced in a cell line. The present invention also relates to compositions and a kit comprising the virosomes according to the invention. Further, the present invention relates to uses and methods involving said virosomes, as well as to a method for preparing same.
Public/Granted literature
Information query
